Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

Modeling at 2023 net pricing estimated semaglutide would avert >358,000 cardiovascular events/deaths, saving ~$15B in cardiovascular care plus ~$8B in other care, but adding ~$344B lifetime drug spend ...

Discover seven cost-effective marketing methods to grow your small business's customer base through digital, traditional, and ...

A joint study by the University of Oulu and the Department of Sports and Exercise Medicine, Oulu Deaconess Institute Foundation highlights the need for better evaluation of both the effectiveness and ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice SOC was dominated by ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

Lifetime treatment with statins is a cost-effective therapy across a wide range of elderly patients with and without cardiovascular disease, according to an analysis published this week in Heart.

CAR-T therapy's cost per QALY is approximately $100,000, with consistent results across PSM, STM, and DES models. DES uniquely incorporates wait time, significantly affecting CAR-T's ...

A new analysis from the Institute for Clinical and Economic Review has found that blockbuster GLP-1 drugs from Novo Nordisk and Eli Lilly offer substantial health benefits and are a cost-effective ...

Based on this analysis, all 3 gepants are not cost-effective compared with usual care for the treatment of acute migraine. Objective: Migraine is a debilitating chronic disorder requiring multifaceted ...